Target intelligence / Profile preview

Unc-51-like autophagy activating kinase 1 (ULK1) and Unc-51-like autophagy activating kinase 2 (ULK2) (ULK1 (for Unc-51-like autophagy activating kinase 1), ULK2 (for Unc-51-like autophagy activating kinase 2))

Target
ULK1 (for Unc-51-like autophagy activating kinase 1), ULK2 (for Unc-51-like autophagy activating kinase 2)
Molecular classification
Enzyme (Protein kinase; specifically serine/threonine kinase), Autophagy regulator, Signaling molecule
01

Overview

ULK kinase-1 and ULK kinase-2 are serine/threonine protein kinases that initiate autophagy by phosphorylating and organizing autophagy-specific regulatory complexes[1]. ULK1, together with FIP200, ATG13, and ATG101, forms the core autophagy induction machinery in mammalian cells, coordinating upstream (nutrient sensing via mTORC1) and downstream molecular events critical for the formation and expansion of autophagosomes. ULK2 is structurally similar (~78% kinase domain identity), yet exhibits unique interaction motifs and regulatory roles, indicating partially overlapping but also distinct biological functions—ULK1 is more involved in apoptosis and intracellular transport, while ULK2 regulates homeostasis and cytokine responses[1][2][4]. Both kinases are increasingly targeted in diseases where autophagy plays a pathogenic role, and inhibitors modulating their catalytic activity are in development for cancer and inflammation[3][4][2].

Other names
ULK1ULK2Unc-51-like kinase 1Unc-51-like kinase 2Autophagy-related protein 1 homolog (ATG1 homolog)Autophagy initiator kinases
02

Mechanism of action

Inhibition of kinase activity (ATP-competitive inhibition blocks autophagy initiation); Conformational modulation of kinase domain; Potential dual inhibition (both ULK1 and ULK2) for robust autophagy blockade

03

Biological functions

Autophagy initiation (formation of autophagosomes)Intracellular transportCellular homeostasisApoptosis regulationMetabolic stress response
04

Disease associations

Cancer (ULK inhibition proposed for autophagy blockade in cancer cells)Inflammatory diseases (e.g., ulcerative colitis)Neurodegenerative disease (by regulating cell survival and protein homeostasis)Metabolic diseases (due to effects on glucose metabolism and homeostasis)Other: aging, infection response, muscle homeostasis
05

Safety considerations

Off-target effects due to kinase domain similarity to other kinasesDisruption of basal autophagy, which may have deleterious effects in non-cancerous tissues (potential for neurodegeneration, immune dysregulation)Possible impact on cellular homeostasis and apoptosis
06

Interacting drugs

Small molecule inhibitors

2 more in the full profile.

07

Biomarkers

Phosphorylation status of ULK1 (e.g., Thr180)Autophagic flux markers (LC3 conversion, p62 degradation)Tissue or cellular expression levels of ULK1/2 in disease contexts (e.g., downregulation in ulcerative colitis)

Beyond the preview

Go deeper on Unc-51-like autophagy activating kinase 1 (ULK1) and Unc-51-like autophagy activating kinase 2 (ULK2) (ULK1 (for Unc-51-like autophagy activating kinase 1), ULK2 (for Unc-51-like autophagy activating kinase 2)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unc-51-like autophagy activating kinase 1 (ULK1) and Unc-51-like autophagy activating kinase 2 (ULK2) (ULK1 (for Unc-51-like autophagy activating kinase 1), ULK2 (for Unc-51-like autophagy activating kinase 2)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call